These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11850247)

  • 1. Evidence of active efflux in resistance to ciprofloxacin and to ethidium bromide by Mycoplasma hominis.
    Raherison S; Gonzalez P; Renaudin H; Charron A; Bébéar C; Bébéar CM
    Antimicrob Agents Chemother; 2002 Mar; 46(3):672-9. PubMed ID: 11850247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus.
    Schmitz FJ; Fluit AC; Lückefahr M; Engler B; Hofmann B; Verhoef J; Heinz HP; Hadding U; Jones ME
    J Antimicrob Chemother; 1998 Dec; 42(6):807-10. PubMed ID: 10052906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active antimicrobial efflux in Staphylococcus epidermidis: building up of resistance to fluoroquinolones and biocides in a major opportunistic pathogen.
    Costa SS; Viveiros M; Pomba C; Couto I
    J Antimicrob Chemother; 2018 Feb; 73(2):320-324. PubMed ID: 29126275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide.
    Couto I; Costa SS; Viveiros M; Martins M; Amaral L
    J Antimicrob Chemother; 2008 Sep; 62(3):504-13. PubMed ID: 18511413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of two multidrug transporter-like genes is associated with ethidium bromide and ciprofloxacin resistance in Mycoplasma hominis.
    Raherison S; Gonzalez P; Renaudin H; Charron A; Bébéar C; Bébéar CM
    Antimicrob Agents Chemother; 2005 Jan; 49(1):421-4. PubMed ID: 15616325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of older and newer fluoroquinolones against efflux-mediated high-level ciprofloxacin-resistant Streptococcus pneumoniae.
    Daporta MT; Muñoz Bellido JL; Guirao GY; Hernández MS; García-Rodríguez JA
    Int J Antimicrob Agents; 2004 Aug; 24(2):185-7. PubMed ID: 15288320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of the multidrug efflux pump LfrA to innate mycobacterial drug resistance.
    Sander P; De Rossi E; Böddinghaus B; Cantoni R; Branzoni M; Böttger EC; Takiff H; Rodriquez R; Lopez G; Riccardi G
    FEMS Microbiol Lett; 2000 Dec; 193(1):19-23. PubMed ID: 11094273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae.
    Zeller V; Janoir C; Kitzis MD; Gutmann L; Moreau NJ
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1973-8. PubMed ID: 9303396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of efflux pump gene pmrA in fluoroquinolone-resistant and -susceptible clinical isolates of Streptococcus pneumoniae.
    Piddock LJ; Johnson MM; Simjee S; Pumbwe L
    Antimicrob Agents Chemother; 2002 Mar; 46(3):808-12. PubMed ID: 11850265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperation between prokaryotic (Lde) and eukaryotic (MRP) efflux transporters in J774 macrophages infected with Listeria monocytogenes: studies with ciprofloxacin and moxifloxacin.
    Lismond A; Tulkens PM; Mingeot-Leclercq MP; Courvalin P; Van Bambeke F
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3040-6. PubMed ID: 18573933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A convenient assay for estimating the possible involvement of efflux of fluoroquinolones by Streptococcus pneumoniae and Staphylococcus aureus: evidence for diminished moxifloxacin, sparfloxacin, and trovafloxacin efflux.
    Beyer R; Pestova E; Millichap JJ; Stosor V; Noskin GA; Peterson LR
    Antimicrob Agents Chemother; 2000 Mar; 44(3):798-801. PubMed ID: 10681364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar typhimurium.
    Giraud E; Cloeckaert A; Kerboeuf D; Chaslus-Dancla E
    Antimicrob Agents Chemother; 2000 May; 44(5):1223-8. PubMed ID: 10770755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single- and multi-step resistance selection study of gemifloxacin compared with trovafloxacin, ciprofloxacin, gatifloxacin and moxifloxacin in Streptococcus pneumoniae.
    Nagai K; Davies TA; Dewasse BE; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 2001 Sep; 48(3):365-74. PubMed ID: 11533001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of a novel efflux-related multidrug resistance phenotype in Staphylococcus aureus.
    Kaatz GW; Moudgal VV; Seo SM
    J Antimicrob Chemother; 2002 Dec; 50(6):833-8. PubMed ID: 12461001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.
    Kowalski RP; Dhaliwal DK; Karenchak LM; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2003 Sep; 136(3):500-5. PubMed ID: 12967804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis.
    Li XZ; Zhang L; Nikaido H
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2415-23. PubMed ID: 15215089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae.
    Brenwald NP; Gill MJ; Wise R
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2032-5. PubMed ID: 9687402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. gyrA and gyrB mutations are implicated in cross-resistance to Ciprofloxacin and moxifloxacin in Clostridium difficile.
    Dridi L; Tankovic J; Burghoffer B; Barbut F; Petit JC
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3418-21. PubMed ID: 12384345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility testing of Singapore strains of Mycoplasma hominis to tetracycline, gatifloxacin, moxifloxacin, ciprofloxacin, clindamycin, and azithromycin by the Etest method.
    Ngan CC; Lim T; Choo CM; Toh GL; Lim YS
    Diagn Microbiol Infect Dis; 2004 Mar; 48(3):207-10. PubMed ID: 15023431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro activity of moxifloxacin against fluoroquinolone-resistant strains of aerobic gram-negative bacilli and Enterococcus faecalis.
    Tankovic J; Bachoual R; Ouabdesselam S; Boudjadja A; Soussy CJ
    J Antimicrob Chemother; 1999 May; 43 Suppl B():19-23. PubMed ID: 10382871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.